Boehringer Ingleheim Pharmaceuticals, Inc. v. Morganti, Inc.
This text of 537 A.2d 171 (Boehringer Ingleheim Pharmaceuticals, Inc. v. Morganti, Inc.) is published on Counsel Stack Legal Research, covering Connecticut Appellate Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
On August 29, 1986, the defendant moved to dismiss the plaintiff’s action for injunctive relief. A hearing on the defendant’s motion to dismiss was scheduled for September 15,1986. On September 11, 1986, the plaintiff filed a motion for extension of time to file its memorandum of law in opposition to the motion to dismiss. No action was taken on that motion and the plaintiff filed its memorandum in opposition the following day. On September 15, 1986, the trial court addressed the merits of the motion to dismiss, and granted the motion. The plaintiff appeals from the granting of that motion.
We find this case to be controlled by our holdings in Czaja v. Sallak, 13 Conn. App. 411, 412, 536 A.2d 1001 (1988), and Burton v. Redding Planning Commission, 13 Conn. App. 400, 408-409, 536 A.2d 995 (1988). In those cases, we held that “the timely filing of a memorandum of law in opposition to a motion to dismiss, pur[752]*752suant to Practice Book § 143,1 is mandatory, and that noncompliance with the five-day time period mandated by § 143 required that the motion be granted without regard to its merits.” Czaja v. Sallak, supra, 412.
There is no error.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
537 A.2d 171, 13 Conn. App. 813, 1988 Conn. App. LEXIS 156, Counsel Stack Legal Research, https://law.counselstack.com/opinion/boehringer-ingleheim-pharmaceuticals-inc-v-morganti-inc-connappct-1988.